📰 Registration Document News
Page 37 - Registration Document News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Document. Real-time updates on events, politics, business and more.
October 20, 2023
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market&...
October 20, 2023
Abivax Announces Trading Resumption of its Ordinary Shares on Euronext ...
October 20, 2023
PARIS, FRANCE / ACCESSWIRE / October 20, 2023 / Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
October 18, 2023
PARIS, FRANCE / ACCESSWIRE / October 18, 2023 / Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
October 18, 2023
EQS-News: ABIVAX / Key word(s): IPOAbivax announces the filing of an amended registration statement, including an estimated initial public offering price range 19.10.2023 / 00:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces the filing of an amended registration state...
October 18, 2023
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the filing of an amended registration statement, including an estimated...
October 16, 2023
EQS-News: ABIVAX / Key word(s): IPOAbivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing 16.10.2023 / 17:40 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces the start of the roadshow for its proposed global offering and p...
October 16, 2023
PARIS, FRANCE / ACCESSWIRE / October 16, 2023 / Abivax SA (PARIS:FR) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's
October 16, 2023
EQS-News: ABIVAX / Key word: IPO Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing 16.10.2023 / 17:40...
October 11, 2023
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains Data from PHAXIAMs phagogram, first...